- Motley Fool•yesterday
Amgen's top-selling anti-inflammatory drug, Enbrel, may have already hit its high-water mark.
- The Wall Street Journal•2 days ago
French drugmaker Sanofi said 1Q net profit jumped to about $6.2 billion, boosted by the sale of its animal-health business. To revive growth, Sanofi has boosted its research and is seeking to acquire an ...
- Motley Fool•2 days ago
Biosimilars begin to take a small bite out of Johnson & Johnson's top line.
JNJ.BA : Summary for JOHNSON & JOHNSON CEDEAR EACH R - Yahoo Finance
Johnson & Johnson (JNJ.BA)
Buenos Aires - Buenos Aires Delayed Price. Currency in ARS
Add to watchlist
|Day's Range||380.00 - 380.00|
|52 Week Range||322.80 - 400.00|
|PE Ratio (TTM)||63.88|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|